Louisiana v. FDA: Access to Mifepristone Back at the Supreme Court - kff.org
The Supreme Court is reviewing Louisiana v. FDA, a case challenging FDA's regulation of mifepristone, which could affect access to the drug and impose new restrictions on pharmacies that dispense it.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on August 31, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Independent pharmacies, retail chains, compounding pharmacies, and long-term-care pharmacies that dispense mifepristone. should confirm how it applies to their specific situation before acting. There is a time constraint attached: No specific deadline provided; the Court's decision is pending.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
The Supreme Court is considering the case Louisiana v. FDA, which challenges the FDA's rules on mifepristone access. The outcome could alter the drug's availability and impose additional dispensing requirements.
Who it affects
Independent pharmacies, retail chains, compounding pharmacies, and long-term-care pharmacies that dispense mifepristone.
What you must do
Monitor the Supreme Court's decision and be prepared to adjust dispensing practices if the FDA's regulations are changed.
Deadline
No specific deadline provided; the Court's decision is pending.
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- Some Utah Pharmacies Can Now Offer Hormonal Contraception Without A Doctor's Visit - upr.org
- Missouri becomes last with statewide prescription database as new program goes online - stlpr.org
- New Illinois Law Gives Doctors Freedom to Prescribe Opioids Without Dosage Limits - painnewsnetwork.org
- Ohio Board of Pharmacy places temporary ban on opioid-like kratom products - daytondailynews.com
- Bill making ivermectin an over-the-counter drug signed by Gov. Greg Abbott - texastribune.org